Bristol-Myers Squibb's MyoKardia, Theravance, Sanofi buyout Principia hit with job cuts - San Francisco Business Times

Three Bay Area biotech companies are trimming staff - two major cuts in the wake of failed clinical trials, the other following its $13 billion acquisition last year.

Read at San Francisco Business Times